Role of stem cell transplantation in myeloma

被引:1
作者
Gahrton, G [1 ]
Iacobelli, S [1 ]
Björkstrand, B [1 ]
Bourhis, J [1 ]
Corradini, P [1 ]
Crawley, C [1 ]
Morris, C [1 ]
Niederwieser, D [1 ]
机构
[1] Karolinska Inst, Dept Med, Stockholm, Sweden
关键词
D O I
10.1080/10245330512331390168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:127 / 128
页数:2
相关论文
共 11 条
[1]   Single versus double autologous stem-cell transplantation for multiple myeloma [J].
Attal, M ;
Harousseau, JL ;
Facon, T ;
Guilhot, F ;
Doyen, C ;
Fuzibet, JG ;
Monconduit, M ;
Hulin, C ;
Caillot, D ;
Bouabdallah, R ;
Voillat, L ;
Sotto, JJ ;
Grosbois, B ;
Bataille, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (26) :2495-2502
[2]   A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma [J].
Attal, M ;
Harousseau, JL ;
Stoppa, AM ;
Sotto, JJ ;
Fuzibet, JG ;
Rossi, JF ;
Casassus, P ;
Maisonneuve, H ;
Facon, T ;
Ifrah, N ;
Payen, C ;
Bataille, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (02) :91-97
[3]  
BOURHIS J, 2005, UNPUB BLOOD
[4]   High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma [J].
Child, JA ;
Morgan, GJ ;
Davies, FE ;
Owen, RG ;
Bell, SE ;
Hawkins, K ;
Brown, J ;
Drayson, MT ;
Selby, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (19) :1875-1883
[5]   Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma [J].
Corradini, P ;
Cavo, M ;
Lokhorst, H ;
Martinelli, G ;
Terragna, C ;
Majolino, I ;
Valagussa, P ;
Boccadoro, M ;
Samson, D ;
Bacigalupo, A ;
Russell, N ;
Montefusco, V ;
Voena, C ;
Gahrton, G .
BLOOD, 2003, 102 (05) :1927-1929
[6]   Molecular and clinical remissions in multiple myeloma: Role of autologous and allogeneic transplantation of hematopoietic cells [J].
Corradini, P ;
Voena, C ;
Tarella, C ;
Astolfi, M ;
Ladetto, M ;
Palumbo, A ;
Van Lint, MT ;
Bacigalupo, A ;
Santoro, A ;
Musso, M ;
Majolino, I ;
Boccadoro, M ;
Pileri, A .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :208-215
[7]  
Crawley C, 2005, BONE MARROW TRANSPL, V35, pS48
[8]   Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma:: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres [J].
Gahrton, G ;
Svensson, H ;
Cavo, M ;
Apperley, J ;
Bacigalupo, A ;
Björkstrand, B ;
Bladé, J ;
Cornelissen, J ;
de Laurenzi, A ;
Facon, T ;
Ljungman, P ;
Michallet, M ;
Niederwieser, D ;
Powles, R ;
Reiffers, J ;
Russell, NH ;
Samson, D ;
Schaefer, UW ;
Schattenberg, A ;
Tura, S ;
Verdonck, LF ;
Vernant, JP ;
Willemze, R ;
Volin, L .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (01) :209-216
[9]   The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma:: reduced relapse risk in female to male transplants [J].
Gahrton, G ;
Iacobelli, S ;
Apperley, J ;
Bandini, G ;
Björkstrand, B ;
Bladé, J ;
Boiron, JM ;
Cavo, M ;
Cornelissen, J ;
Corradini, P ;
Kröger, N ;
Ljungman, P ;
Michallet, M ;
Russell, NH ;
Samson, D ;
Schattenberg, A ;
Sirohi, B ;
Verdonck, LF ;
Volin, L ;
Zander, A ;
Niederwieser, D .
BONE MARROW TRANSPLANTATION, 2005, 35 (06) :609-617
[10]   Benefit and timing of second transplantations in multiple myeloma: Clinical findings and methodological limitations in a European group for blood and marrow transplantation registry study [J].
Morris, C ;
Iacobelli, S ;
Brand, R ;
Bjorkstrand, B ;
Drake, M ;
Niederwieser, D ;
Gahrton, G .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) :1674-1681